Pepgen Stock Cash And Equivalents
| PEPG Stock | USD 1.29 0.15 10.42% |
PepGen fundamentals help investors to digest information that contributes to PepGen's financial success or failures. It also enables traders to predict the movement of PepGen Stock. The fundamental analysis module provides a way to measure PepGen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PepGen stock.
PepGen |
PepGen Company Cash And Equivalents Analysis
PepGen's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current PepGen Cash And Equivalents | 218.82 M |
Most of PepGen's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PepGen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, PepGen has 218.82 M in Cash And Equivalents. This is 73.34% lower than that of the Biotechnology sector and 51.06% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 91.9% higher than that of the company.
PepGen Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PepGen's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PepGen could also be used in its relative valuation, which is a method of valuing PepGen by comparing valuation metrics of similar companies.PepGen is currently under evaluation in cash and equivalents category among its peers.
PepGen Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | (77.77 M) | ||||
| Shares Outstanding | 32.6 M | ||||
| Shares Owned By Insiders | 0.02 % | ||||
| Shares Owned By Institutions | 96.39 % | ||||
| Number Of Shares Shorted | 736.57 K | ||||
| Price To Book | 0.31 X | ||||
| EBITDA | (83.58 M) | ||||
| Net Income | (78.63 M) | ||||
| Cash And Equivalents | 218.82 M | ||||
| Cash Per Share | 9.26 X | ||||
| Total Debt | 20.1 M | ||||
| Current Ratio | 11.01 X | ||||
| Book Value Per Share | 4.22 X | ||||
| Cash Flow From Operations | (69 M) | ||||
| Short Ratio | 3.68 X | ||||
| Earnings Per Share | (2.98) X | ||||
| Target Price | 12.8 | ||||
| Number Of Employees | 76 | ||||
| Beta | 1.76 | ||||
| Market Capitalization | 42.05 M | ||||
| Total Asset | 143.05 M | ||||
| Retained Earnings | (181.48 M) | ||||
| Working Capital | 95.15 M | ||||
| Net Asset | 143.05 M |
About PepGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PepGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PepGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PepGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out PepGen Piotroski F Score and PepGen Altman Z Score analysis. For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PepGen. If investors know PepGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PepGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PepGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if PepGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PepGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.